Explainer: How the Merck/Moderna cancer vaccine works and possible barriers to wide use

Moderna and Merck’s personalized cancer vaccine has raised hopes for mRNA as a new cancer treatment avenue, but the evidence base remains limited. While the development is encouraging for biotech innovation, current data constraints suggest outsized upside is not yet fully supported.